1. Home
  2. BDTX vs UIS Comparison

BDTX vs UIS Comparison

Compare BDTX & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • UIS
  • Stock Information
  • Founded
  • BDTX 2014
  • UIS 1942
  • Country
  • BDTX United States
  • UIS United States
  • Employees
  • BDTX N/A
  • UIS N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • UIS EDP Services
  • Sector
  • BDTX Health Care
  • UIS Technology
  • Exchange
  • BDTX Nasdaq
  • UIS Nasdaq
  • Market Cap
  • BDTX 349.4M
  • UIS 294.9M
  • IPO Year
  • BDTX 2020
  • UIS N/A
  • Fundamental
  • Price
  • BDTX $6.11
  • UIS $4.70
  • Analyst Decision
  • BDTX Strong Buy
  • UIS
  • Analyst Count
  • BDTX 3
  • UIS 0
  • Target Price
  • BDTX $13.00
  • UIS N/A
  • AVG Volume (30 Days)
  • BDTX 799.4K
  • UIS 321.2K
  • Earning Date
  • BDTX 08-09-2024
  • UIS 07-30-2024
  • Dividend Yield
  • BDTX N/A
  • UIS N/A
  • EPS Growth
  • BDTX N/A
  • UIS N/A
  • EPS
  • BDTX N/A
  • UIS N/A
  • Revenue
  • BDTX N/A
  • UIS $1,986,800,000.00
  • Revenue This Year
  • BDTX N/A
  • UIS $0.77
  • Revenue Next Year
  • BDTX N/A
  • UIS $3.15
  • P/E Ratio
  • BDTX N/A
  • UIS N/A
  • Revenue Growth
  • BDTX N/A
  • UIS N/A
  • 52 Week Low
  • BDTX $1.62
  • UIS $2.60
  • 52 Week High
  • BDTX $7.66
  • UIS $8.12
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 64.77
  • UIS 56.30
  • Support Level
  • BDTX $5.54
  • UIS $4.54
  • Resistance Level
  • BDTX $6.28
  • UIS $4.95
  • Average True Range (ATR)
  • BDTX 0.36
  • UIS 0.19
  • MACD
  • BDTX 0.12
  • UIS 0.04
  • Stochastic Oscillator
  • BDTX 96.55
  • UIS 65.54

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides solutions that transform digital workplaces securely and create exceptional end-user experiences. CA&I provides digital platform, applications and infrastructure solutions. ECS provides solutions that harness secure, continuous high-intensity computing and enable digital services through software-defined operating environments.

Share on Social Networks: